UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000007099
Receipt No. R000008362
Official scientific title of the study prospective study of vitrectomy with heavy silicone oil for Japanese patients
Date of disclosure of the study information 2012/01/22
Last modified on 2017/01/10 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study prospective study of vitrectomy with heavy silicone oil for Japanese patients
Title of the study (Brief title) prospective study of vitrectomy with heavy silicone oil for Japanese patients
Region
Japan

Condition
Condition proliferative vitreoretinopathy
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the efficacy of treatment for proliferative vitreoretinopathy
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes visual acuity
Key secondary outcomes postoperative complications

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 October 2011~December 2020
tamponade agent of vitrectomy for proliferative vitreoretinopathy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria proliferative vitreoretinopathy
Key exclusion criteria proliferative vitreoretinopathy
Target sample size 15

Research contact person
Name of lead principal investigator Taiji Sakamoto
Organization Graduate School of Medical and Dental Science, Kagoshima University
Division name Department of Ophthalmology
Address Sakuragaoka 8-35-1,Kagoshima
TEL 099-275-5111
Email tsakamot@m3.kufm.kagoshima-u.ac.jp

Public contact
Name of contact person Toshifumi Yamashita
Organization Graduate School of Medical and Dental Science, Kagoshima University
Division name Department of Ophthalmology
Address Sakuragaoka 8-35-1,Kagoshima
TEL 099-275-5111
Homepage URL
Email yyamatos@m.kufm.kagoshima-u.ac.jp

Sponsor
Institute Department of Ophthalmology, Graduate School of Medical and Dental Science, Kagoshima University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 鹿児島大学病院(鹿児島県)

Other administrative information
Date of disclosure of the study information
2012 Year 01 Month 22 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2011 Year 10 Month 31 Day
Anticipated trial start date
2011 Year 11 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 01 Month 19 Day
Last modified on
2017 Year 01 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008362